Pfizer Inc (PFE) 35.71 $PFE Bull Chart of the Day:

New Post Public Reply Private Reply Replies (0) Message Board

Jul 29, 2015 at 1:43 PM

Pfizer Inc (PFE) 35.71 $PFE

Bull Chart of the Day: Pfizer
at The Street - 2 hrs 48 mins ago
PFE now has a very large bull flag with the potential to push the shares higher.
PFE: 35.71 (+0.36)

Stock Market News for July 29, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 9:10AM CDT
Benchmarks gained over 1% on Tuesday as investors focused on upbeat earnings results, ignoring the selloff in China’s stock market
BIIB: 311.50 (-8.43), F: 15.12 (+0.29), RIG: 14.33 (+0.21), GILD: 116.55 (+3.48), PFE: 35.71 (+0.36), COP: 52.72 (+0.48), XOM: 82.68 (+0.20), AMGN: 169.99 (-2.75), DD: 55.64 (-0.26), CVX: 92.68 (+0.28), SLB: 83.46 (+0.96), UPS: 100.60 (+0.66), CELG: 132.91 (-2.51)

Watch for Shares of Pfizer (PFE) to Approach Resistance at $36.14
Comtex SmarTrend(R) - Wed Jul 29, 9:04AM CDT
Pfizer (NYSE

FE) has opened bullishly above the pivot of $35.07 today and has reached the first level of resistance at $35.75. Investors may be interested in a cross of the next upside pivot targets of $36.14 and $37.21.
PFE: 35.71 (+0.36)

Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies
at The Street - Wed Jul 29, 6:40AM CDT
Here's a closer look at Renaissance Technologies' 10 largest new holdings in the most recently reported quarter.
CCI: 82.14 (-0.12), AMZN: 526.96 (+0.93), FB: 96.12 (+0.83), PFE: 35.71 (+0.36), VFC: 75.31 (-0.34), WMT: 72.35 (+0.25), TWTR: 31.56 (-4.98), UNP: 97.07 (+0.45), REGN: 541.09 (-11.36), PCLN: 1,218.70 (+10.61)

Hospira Reports Second-Quarter 2015 Results
PR Newswire - Wed Jul 29, 6:30AM CDT
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today reported results for the second quarter ended June 30, 2015. For the second quarter of 2015, net sales were $1.2 billion, and adjusted* diluted earnings per share were $0.85. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles (GAAP) basis, second-quarter 2015 diluted earnings per share were $0.82.
PFE: 35.71 (+0.36), HSP: 89.26 (+0.03)

Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Tue Jul 28, 8:12PM CDT
The following Pfizer (PFE) conference call took place on July 28, 2015, 10:00 AM ET. This is a transcript of that earnings call:
PFE: 35.71 (+0.36)

Big pharmas beat Q2 views
at Investor's Business Daily - Tue Jul 28, 5:42PM CDT
Pfizer's (PFE) EPS dipped 3% to 56 cents, topping by 4 cents. Sales declined 7% to $11.85 bil, ahead of views. It raised its full-year EPS to $2.01-$2.07, in line with views, and upped the low end of its sales guidance. Merck's (MRK) EPS rose 1% to...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36)

Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - Tue Jul 28, 4:32PM CDT
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16), SNY: 53.88 (+0.07), REGN: 541.09 (-11.36)

After Yesterday's Rally of 2.94% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 28, 4:29PM CDT
Pfizer (NYSE

FE) traded in a range yesterday that spanned from a low of $34.40 to a high of $35.47. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $35.00 on volume of 36.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PFE: 35.71 (+0.36)

SuperValu and Pfizer are big market movers
AP - Tue Jul 28, 3:32PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
RAI: 83.82 (-0.38), QSR.TO: 55.54 (+0.19), RJET: 5.29 (+1.85), SVU: 8.69 (+0.55), PFE: 35.71 (+0.36), IR: 61.58 (+0.88), MYL: 57.08 (+0.73), BECN: 36.32 (+2.73), MAS: 26.06 (+0.43), PGNX: 8.80 (-0.62), QSR: 43.07 (+0.32), TEVA: 71.06 (-0.35), WAB: 101.25 (+1.63), IPGP: 92.03 (+2.32)

Stocks Rebound Sharply, Helped by Higher Oil Prices
at The Street - Tue Jul 28, 3:05PM CDT
Markets came back with a bang on Tuesday, rallying for the first time in six sessions.
F: 15.12 (+0.29), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)

Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - Tue Jul 28, 2:01PM CDT
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.71 (+0.36)

Stocks Rally as Crude Oil Closes Near $48
at The Street - Tue Jul 28, 2:00PM CDT
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 15.12 (+0.29), BIDU: 168.25 (+0.22), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), BP: 37.25 (-0.04), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), UPS: 100.60 (+0.66), XLE: 70.95 (+0.48)

Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - Tue Jul 28, 12:35PM CDT
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 58.58 (+1.06), PFE: 35.71 (+0.36), BMY: 64.50 (-0.16)

Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 526.96 (+0.93), F: 15.12 (+0.29), HON: 105.56 (+1.36), PFE: 35.71 (+0.36), XOM: 82.68 (+0.20), COP: 52.72 (+0.48), UPS: 100.60 (+0.66), BIDU: 168.25 (+0.22), EBAY: 28.85 (+0.52), MRK: 58.58 (+1.06), DD: 55.64 (-0.26), BP: 37.25 (-0.04), PG: 80.77 (+0.54), CVX: 92.68 (+0.28), PTR: 102.42 (+3.19), XLE: 70.95 (+0.48)

China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.71 (+0.36), DD: 55.64 (-0.26), UPS: 100.61 (+0.67)

Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.71 (+0.36)

Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.71 (+0.36), INVN: 12.53 (-0.88), COP: 52.72 (+0.48), TEVA: 71.06 (-0.35), TWTR: 31.57 (-4.97)

Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.39 (+0.30), PFE: 35.71 (+0.36), LLY: 85.06 (-0.62), HSP: 89.26 (+0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

BMAP Expands: Bridging Borders in Legal Advocacy

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Koogler's Sale to ALL4: A Game-Changer for the Southeast

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Paula's Choice Elevates Skincare Game with New Campaign

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Citrine Finalizes Sale of Illinois Senior Living Asset

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

NY Sheriffs' Court Battle: Immigration Policies Under Fire

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

WellLink Advisory Board Eyes Future of Healthcare Innovation

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....